Company Overview and News

107
Opko Health: If These SEC Charges Were Surprising Then You Haven't Been Paying Attention

2018-09-11 seekingalpha - 6
Opko's stock is now halted following SEC charges alleging fraud by both the company and its Chairman & CEO Phil Frost.
RIOT OPK IZEA MARA CDXC VBIV COCP PGLC BIOP

1
PGLC / Pershing Gold Corporation 424B3 (Prospectus)

2018-08-31 sec.gov - 1
Filed Pursuant to Rule 424(b)(3) Registration No. 333-222612 PROSPECTUS
PGLC

 
PGLC / Pershing Gold Corporation / Honig Barry C - SC 13D/A (Activist Investment)

2018-08-30 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PGLC

1
PGLC / Pershing Gold Corporation / Honig Barry C - SC 13D/A (Activist Investment)

2018-08-30 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
PGLC

 
Levon Resources Announces Sale of Pershing Gold Corporation Shares

2018-08-29 globenewswire
VANCOUVER, British Columbia, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Levon Resources Ltd. (TSX:LVN) (OTCQX: LVNVF) (“Levon” or “the Company”) announces that pursuant to a private transaction, it has sold 1,884,810 common shares of Pershing Gold Corporation in exchange for consideration of US$3,864,158. The consideration paid to Levon consists of US$1,968,928 in cash and 9,003,467 common shares of Levon (the “Levon Shares”).
LVN PGLC LVVNF LVNVF

 
PGLC / Pershing Gold Corporation POS AM

2018-08-21 sec.gov
As filed with the Securities and Exchange Commission on August 21, 2018. Registration No. 333-222612
PGLC

7
The Zacks Analyst Blog Highlights: Timmons Gold, Northern Dynasty Minerals, New Gold, Sibanye Gold and Pershing Gold

2018-08-21 zacks - 2
Chicago, IL – August 21, 2018 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Timmons Gold Corp (ALO - Free Report) , Northern Dynasty Minerals Ltd. (NAK - Free Report) , New Gold Inc. (NGD - Free Report) , Sibanye Gold Limited (SBGL - Free Report) and Pershing Gold Corporation (PGLC - Free Report) .
VRTX NGD FIX NGDAF RDN MDR NGD JOUT CCBG NDMWF SBGL.WI BSTC MLNX NAK ADM PGLC MCDFF NSIT

7
Gold Nears 19-Month Low: 5 Worst Stocks YTD

2018-08-20 investorplace
After a blockbuster start to the year, gold has fallen out of investors’ favor, thanks to rising interest rates and a strong dollar. The yellow metal logged in the sixth consecutive weekly decline and the worst weekly drop since December, shedding 2.2% last week. This followed the metal’s fourth consecutive monthly decline in July that represents the longest stretch of losses since 2013.
SBGL NDMWF SBGL.WI NGD ALO NGDAF NAK PGLC NGD

5
Gold Nears 19-Month Low: 5 Worst Stocks YTD

2018-08-20 zacks
After a blockbuster start to the year, gold has fallen out of investors’ favor, thanks to rising interest rates and a strong dollar. The yellow metal logged in the sixth consecutive weekly decline and the worst weekly drop since December, shedding 2.2% last week. This followed the metal’s fourth consecutive monthly decline in July that represents the longest stretch of losses since 2013. Notably, the bullion remained near 19-month lows and has tumbled 14% since its peak in April.
NDMWF NGD SBGL.WI NAK NGDAF NGD PGLC

1
PGLC / Pershing Gold Corporation FORM 10-Q (Quarterly Report)

2018-08-14 sec.gov - 1
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
PGLC

25
GDX: It's A Bear Market, You Know

2018-08-08 seekingalpha
The Gold Miners Index has made another 52-week low and continues to trade in a bear market.
NGD KGI KGI.DB.A KGI.DB NGDAF NGD RGLD SBGL.WI AKG ELD GORO PGLC AKG KL EGO RGL

1
PGLC / Pershing Gold Corporation 424B3 (Prospectus)

2018-06-28 sec.gov
Filed Pursuant to Rule 424(b)(3) Registration No. 333-222612 PROSPECTUS SUPPLEMENT NO. 7 TO THE PROSPECTUS DATED JA
PGLC

1
PGLC / Pershing Gold Corporation FORM 8-K (Current Report)

2018-06-27 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMI
PGLC

51
Resource Sector Digest: Sandstorm Gold And The Beauty Of Depletion

2018-06-05 seekingalpha - 1
In case you missed out on previous editions of this newsletter, simply click here, here or here to catch up.
HRT MGG HRTFF MMRGF GFI.WI FNV NEM NMKEF RSG PRB RNX RNKLF KGC NMX RMGGF FQVLF AEM MACIF AG FQM GFIOF NDM WPM RPM FR SAND FNV.WT.A SSL GPL SDDXF ALO PROBF K RPMGD WHGOF RPMGF SNXZF ORG RGLD RNX.WT RMGGY GFI PGLC CANWF FNV RGL

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

16h - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

17h - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

19h - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to PGLC / Pershing Gold Corporation on message board site Silicon Investor.

PERSHING GOLD...PGLC PERSHING GOLD...PGLC PERSHING GOLD...PGLC
CUSIP: 715302204